Fermenta Biotech Limited (BOM:506414)
312.80
+1.45 (0.47%)
At close: Feb 12, 2026
Fermenta Biotech Revenue
Fermenta Biotech had revenue of 1.37B INR in the quarter ending December 31, 2025, a decrease of -12.21%. This brings the company's revenue in the last twelve months to 5.44B, up 27.34% year-over-year. In the fiscal year ending March 31, 2025, Fermenta Biotech had annual revenue of 4.69B with 39.87% growth.
Revenue (ttm)
5.44B
Revenue Growth
+27.34%
P/S Ratio
1.68
Revenue / Employee
8.97M
Employees
606
Market Cap
9.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 4.69B | 1.34B | 39.87% |
| Mar 31, 2024 | 3.36B | -142.79M | -4.08% |
| Mar 31, 2023 | 3.50B | -485.75M | -12.19% |
| Mar 31, 2022 | 3.99B | 212.27M | 5.63% |
| Mar 31, 2021 | 3.77B | 843.40M | 28.79% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.30B |
| Anuh Pharma | 7.68B |
| Venus Remedies | 7.03B |
| Wanbury | 6.58B |
| Sudarshan Pharma Industries | 6.44B |
| Lincoln Pharmaceuticals | 6.32B |
| Kopran | 6.20B |
| Fredun Pharmaceuticals | 5.31B |